These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12723515)

  • 21. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
    Font A; Gines C; Closa JM; Mascort J
    J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Visceral leishmaniasis in infants without bioptic demonstration of the parasite. Presentation of 3 cases].
    Cataldo F; Violante M; Bellia L; Traverso MG; Albeggiani A
    Pediatr Med Chir; 1989; 11(1):81-4. PubMed ID: 2717490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudo-acute transformation of an idiopathic myelofibrosis due to kala-azar.
    Disdier P; Swiader L; Serratrice J; Mary C; Weiller PJ
    Br J Haematol; 1998 Feb; 100(2):449. PubMed ID: 9488642
    [No Abstract]   [Full Text] [Related]  

  • 24. Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.
    Garcia-Cordoba F; Ortuño FJ; Segovia M; Gonzalez Diaz G
    Ann Trop Med Parasitol; 2005 Mar; 99(2):125-30. PubMed ID: 15814031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Our experiences in visceral leishmaniasis therapy.
    Titone L; Scarlata F; Cascio A; Giordano S; Mancuso G
    J Chemother; 1989 Jul; 1(4 Suppl):960-1. PubMed ID: 16312722
    [No Abstract]   [Full Text] [Related]  

  • 26. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early antimoniate poisoning in a non-fatal visceral leishmaniasis kidney transplant recipient with renal failure.
    Esteban RJ; Bravo JA; Osuna A; Asensio C
    Nephrol Dial Transplant; 1996 Sep; 11(9):1898. PubMed ID: 8918659
    [No Abstract]   [Full Text] [Related]  

  • 28. Visceral leishmanisis in paediatrics: a study of 367 cases in southwest Iran.
    Ashkan MM; Rahim KM
    Trop Doct; 2008 Jul; 38(3):186-8. PubMed ID: 18628558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Kala-azar. Apropos of a case report in a Belgian woman].
    Coutellier P; Delgrange B
    Acta Clin Belg; 1989; 44(5):362-3. PubMed ID: 2609847
    [No Abstract]   [Full Text] [Related]  

  • 30. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.
    Dursun O; Erişir S; Yeşilipek A
    Turk J Pediatr; 2009; 51(1):1-5. PubMed ID: 19378883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short report: Contribution of quantitative real-time polymerase chain reaction to follow-up of visceral leishmaniasis patients treated with meglumine antimoniate.
    Aoun K; Chouihi E; Amri F; Ben Alaya N; Raies A; Mary C; Bouratbine A
    Am J Trop Med Hyg; 2009 Dec; 81(6):1004-6. PubMed ID: 19996428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First report of the use of meglumine antimoniate for treatment of canine leishmaniasis in a pregnant dog.
    Spada E; Proverbio D; Groppetti D; Perego R; Grieco V; Ferro E
    J Am Anim Hosp Assoc; 2011; 47(1):67-71. PubMed ID: 21164165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
    Laguna F; Videla S; Jiménez-Mejías ME; Sirera G; Torre-Cisneros J; Ribera E; Prados D; Clotet B; Sust M; López-Vélez R; Alvar J;
    J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of visceral leishmaniasis.
    Ozsoylu S
    Am J Dis Child; 1992 Sep; 146(9):1021. PubMed ID: 1514542
    [No Abstract]   [Full Text] [Related]  

  • 35. [Relapse of visceral leishmaniasis in HIV infection. Benefit of amphotericin B].
    Kilani B; Amari L; Belhaj S; Goubontini A; Ben Chaabene T
    Tunis Med; 2004 Mar; 82(3):316-9. PubMed ID: 15382468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Visceral leishmaniasis with benign course in a patient infected with human immunodeficiency virus].
    Ribelles N; Casals A; Vallés J; Clotet B
    Med Clin (Barc); 1989 May; 92(17):679. PubMed ID: 2747338
    [No Abstract]   [Full Text] [Related]  

  • 37. Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient.
    Moulin B; Ollier J; Bouchouareb D; Purgus R; Olmer M
    Nephron; 1992; 60(3):360-2. PubMed ID: 1565190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Visceral leishmaniasis in immunocompetent adult with severe sepsis].
    Ezzouine H; Charra B; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2010 Mar; 29(3):255-6. PubMed ID: 20227234
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case.
    Gomes MAF; Medeiros LLC; Lobo FPD; Wanderley NRS; Matos APR; Jácome TDN; Monteiro MGL; Luz KG
    Rev Soc Bras Med Trop; 2018; 51(3):393-396. PubMed ID: 29972577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case report of Kala-Azar in a kidney transplant patient.
    Malek Hosseini SA; Javid R; Salahi H; Nezakatgoo N; Ahmad E; Ghahramani N
    Transplant Proc; 1995 Oct; 27(5):2715. PubMed ID: 7482886
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.